Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alogliptin in combination with alfa-glucosidase inhibitor in Japanese subjects with type 2 diabetes
jRCT2080220567Phase 3
- Sponsor
- Takeda
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Alogliptin + voglibose with Placebo + voglibose (2 arms).
02
Drugs
alogliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT2080220567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220567.